Not Yet Recruiting
Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
NCT06660862
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
- Locations
-
- o University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States